🧬🧪 #SimonBarnett is an analyst at #ARKInvest on the genomic revolution strategy (found in #ARKG and #ARKK), where he focuses on next-generation DNA sequencing, #bioinformatics, molecular #diagnostics, and synthetic biology. We discuss what the future holds for these disruptive technologies and how Simon's focus areas at @ARKInvest2015are converging to change the #healthcare landscape.

💬 Find Simon Barnett on Twitter: sbarnettARK

Simon's latest publication: PacBio ($PACB) Doubles Down on Accuracy by Acquiring Omniome: [ Ссылка ]

🕑 TIMESTAMPS FOR THIS EXCLUSIVE INTERVIEW 🕑
00:00:00 Introduction
00:00:56 Simon's Background & ARK Invest
00:02:53 Healthcare Today
00:09:18 Challenges with Healthcare Data
00:17:00 Steep Cost Curve Declines
00:23:05 Performance Metrics Besides Cost
00:33:42 Huge Advances in Diagnostics
00:43:34 Changing the Diagnostic Funnel
00:57:28 The Central Dogma of Biology
01:03:26 Google DeepMind and AlphaFold
01:15:20 Exciting Converging Technologies
01:27:17 Monogenic vs Polygenic Diseases
01:35:56 Regulatory Risks and Concerns
01:40:12 How the Patient Experience is Changing
01:49:43 Exciting Emerging Industries
01:51:19 Simon's Journey to ARK Invest
01:56:23 Closing Thoughts

🔥 Channel Membership - Join the family!
[ Ссылка ]

🙏 Not into YouTube Memberships but still want to support the channel? [ Ссылка ]

💬 Find me on Twitter: [ Ссылка ]

🎤 My free Discord: [ Ссылка ]

👇 RELEVANT RESOURCES FOR FURTHER RESEARCH 👇

🧬 ARKG | MASSIVE Breakthrough for ARK Invest's Genomics Stocks: [ Ссылка ]

🤩 Cathie Wood's Favorite Stock | ARK Invest Buys This Over Tesla Stock (My Deep Dive into TDOC stock): [ Ссылка ]

💔 IT'S OVER! ARK Invest's $700M Breakup with Illumina (ILMN) - A Case Study in Conviction: [ Ссылка ]

🧬🧪 ARKG: ARK Invest's BEST ETF | Editing Out Disease With ARK's Genomic Revolution Fund: [ Ссылка ]

🧠 Deep Learning: This Disruptive Innovation Could Rewrite (or Erase) Us All: [ Ссылка ]

The Genomics Age of Cancer Screening: Earlier Cancer Detection (Simon Barnett, ARK Invest): [ Ссылка ]

Clinical Trials That Include Genomic Biomarkers Should Pave the Way for Precision Medicine (Simon Barnett, ARK Invest): [ Ссылка ]

🌐 My full resource library: [ Ссылка ] (work in progress)

📃 CHECK OUT MY CURATED PLAYLISTS 📃
⚡ Investing in Disruptive Innovation Starts with Understanding It: [ Ссылка ]

💸 Deep Dives Into My Favorite Growth Stocks:
[ Ссылка ]

📊 Analyzing ARK Invest's Funds: [ Ссылка ]

🤓 My Free Online ARK Fund Calculator:
[ Ссылка ]

📈 Learn What Moves the mARKets: [ Ссылка ]

💡 My Best Investing Insights: [ Ссылка ]

ARK Invest's Thematic Funds:
ARK Invest Innovation ETF (ARKK) - [ Ссылка ]
ARK Invest Genomic Revolution ETF (ARKG) - [ Ссылка ]
ARK Invest Autonomous Technology & Robotics ETF (#ARKQ) - [ Ссылка ]
ARK Invest Next Generation Internet ETF (#ARKW) - [ Ссылка ]
ARK Invest Fintech Innovation ETF (#ARKF) - [ Ссылка ]
ARK Invest Space Exploration ETF (#ARKX) - [ Ссылка ]

Disclaimer: ARK Invest has positions in GOOG (Google stock), TDOC (Teladoc stock), CRSP (Crispr Stock), PACB (Pacific Biosciences), and other companies mentioned in this interview. This content is for discussion and illustrative purposes only and should not be construed as professional financial advice or recommendation to buy or sell any securities. Should you need such advice, consult a licensed financial or tax advisor. All views expressed are personal opinion as of date of recording and are subject to change without responsibility to update views. No guarantee is given regarding the accuracy of information on this channel. Neither host or guests can be held responsible for any direct or incidental loss incurred by applying any of the information offered. I am not a financial advisor or affiliated with ARK Invest in any way.

Thanks for watching!

свернуть